111
Participants
Start Date
July 5, 2005
Primary Completion Date
March 14, 2008
Study Completion Date
March 14, 2008
Gemcitabine
Gemcitabine 1000 mg/m\^2 30 minutes IV infusion on Day 1, 8 and 15 of each cycle, in cycles of 4 weeks
AG-013736
Axitinib (AG-013736) 5 mg tablet orally BID starting from Day 1 of Cycle 1, in cycles of 4 weeks.
Gemcitabine
Gemcitabine 1000 mg/m\^2 30 minutes IV infusion on Day 1, 8 and 15 of each cycle, in cycles of 4 weeks.
Universitair Ziekenhuis Gent/Dienst Gastroenterologie, Ghent
Hopital La Timone, Marseille
Medizinische Klinik mit Schwerpunkt Haematologie und Onkologie, Charité-Universitaetsmedizin Berlin, Berlin
Fondazione IRCCS, Istituto Nazionale Tumori, Oncologia Medica B, Milan
Piedmont Hematology Oncology Association, Winston-Salem
Piedmont Hematology Oncology Associates, Winston-Salem
Institut Claudius Regaud, Toulouse
Jackson Memorial Hospital & Clinics, Miami
University of Miami Hospital & clinics, Miami
Hospital Universitario Virgen Del Rocio, Seville
Service Oncologie Medicale, Saint-Herblain
University of Wisconsin Hospital and Clinics, Madison
Arch Medical Services, Inc. d/b/a The Center for Cancer Care and Research, Washington
Arch Medical Services, Inc. d/b/a The Center for Cancer Care and Research, St Louis
Southeast Nebraska Cancer Center, Southeast Nebraska Hematology and Oncology Consultants, P.C., Lincoln
Hopital de la Pitie Salpetriere, Paris
East Bay Medical Oncology/Hematology Medical Associates Inc., Antioch
Bay Area Cancer Research Group, Concord
East Bay Medical Oncology/Hematology Medical Associates, Inc., Concord
Alta Bates Comprehensive Cancer Center, Berkeley
Hematology Oncology, P.C., Stamford
H Lee Moffitt Cancer Center & Research Institute, Tampa
Maine Center for Cancer Medicine and Blood Disorders, Biddeford
Maine Center for Cancer Medicine and Blood Disorders, Brunswick
Maine Center for Cancer Medicine and Blood Disorders, Scarborough
Cross Cancer Institute, Edmonton
Cancer Care Manitoba, Winnipeg
CancerCare Manitoba, Winnipeg
Sault Area Hospital, Sault Ste. Marie
Princess Margaret Hospital, Toronto
CHUM, Hopital Saint-Luc, Montreal
Unita Operativa, Oncologia Medica, Istituto di Medicina Interna e Geriatria, Roma
Hospital Universitario Vall D´Hebron, Barcelona
Hospital Clinic I Provincial de Barcelona, Barcelona
Cancer Research Uk Clinical Centre, Southampton
Department of Cancer Studies & Molecular Medicine, Leicester
Western General Hospitals Nhs Trust, Edinburgh
Hammersmith Hospital, London
Lead Sponsor
Pfizer
INDUSTRY